# Andrew J. Pollard

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrew-j-pollard/

## Facts

| Field | Value |
| --- | --- |
| Citations | 70,014 |
| Field | Bacterial Infections and Vaccines |
| h-index | 116 |
| i10-index | 648 |
| Last Known Institution | Oxford Research Group |
| OpenAlex ID | https://openalex.org/A5065914659 |
| ORCID iD | https://orcid.org/0000-0001-7361-719X |
| Works | 1,202 |

## Researcher papers

- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial](https://scholariq.org/papers/safety-and-immunogenicity-of-the-chadox1-ncov-19-vaccine-against-sars-cov-2-a/)
- [Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials](https://scholariq.org/papers/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose/)
- [COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II](https://scholariq.org/papers/covid-19-vaccine-hesitancy-in-the-uk-the-oxford-coronavirus-explanations/)
- [T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial](https://scholariq.org/papers/t-cell-and-antibody-responses-induced-by-a-single-dose-of-chadox1-ncov-19/)
- [A CD8+ T cell transcription signature predicts prognosis in autoimmune disease](https://scholariq.org/papers/a-cd8-t-cell-transcription-signature-predicts-prognosis-in-autoimmune-disease/)
- [Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses](https://scholariq.org/papers/phase-1-2-trial-of-sars-cov-2-vaccine-chadox1-ncov-19-with-a-booster-dose/)

## Researcher topics

- [Bacterial Infections and Vaccines](https://scholariq.org/topics/bacterial-infections-and-vaccines/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Salmonella and Campylobacter epidemiology](https://scholariq.org/topics/salmonella-and-campylobacter-epidemiology/)

## Researcher university

- [Oxford Research Group](https://scholariq.org/institutions/oxford-research-group/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.